374 related articles for article (PubMed ID: 36034466)
21. Identifying a Ferroptosis-Related Gene Signature for Predicting Biochemical Recurrence of Prostate Cancer.
Lv Z; Wang J; Wang X; Mo M; Tang G; Xu H; Wang J; Li Y; Liu M
Front Cell Dev Biol; 2021; 9():666025. PubMed ID: 34778244
[TBL] [Abstract][Full Text] [Related]
22. Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma.
Xu Y; Chen Y; Niu Z; Yang Z; Xing J; Yin X; Guo L; Zhang Q; Yang Y; Han Y
Front Surg; 2022; 9():860806. PubMed ID: 35937602
[TBL] [Abstract][Full Text] [Related]
23. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer.
Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z
Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485
[TBL] [Abstract][Full Text] [Related]
24. Clinical Significance and Immune Landscape of Recurrence-Associated Ferroptosis Signature in Early-Stage Lung Adenocarcinoma.
Yi L; Huang P; Gu Y; Wu G; Zou X; Guo L; Wen C; Zhu J; Zhao D
Front Oncol; 2022; 12():794293. PubMed ID: 35155238
[TBL] [Abstract][Full Text] [Related]
25. SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer.
Luo C; Liu Z; Gan Y; Gao X; Zu X; Zhang Y; Ye W; Cai Y
J Transl Med; 2022 Jul; 20(1):313. PubMed ID: 35836192
[TBL] [Abstract][Full Text] [Related]
26. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
[TBL] [Abstract][Full Text] [Related]
27. Molecular characteristics, clinical significance, and cancer immune interactions of cuproptosis and ferroptosis-associated genes in colorectal cancer.
Li Y; Wang RY; Deng YJ; Wu SH; Sun X; Mu H
Front Oncol; 2022; 12():975859. PubMed ID: 36132144
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment.
Hu B; Zhang X; Zhu S; Wang C; Deng Z; Wang T; Wu Y
Eur J Med Res; 2024 Jan; 29(1):92. PubMed ID: 38297388
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
[TBL] [Abstract][Full Text] [Related]
30. Identification of recurrence marker associated with immune infiltration in prostate cancer with radical resection and build prognostic nomogram.
Rui X; Shao S; Wang L; Leng J
BMC Cancer; 2019 Dec; 19(1):1179. PubMed ID: 31795990
[TBL] [Abstract][Full Text] [Related]
31. A Novel Ferroptosis-Related Gene Model for Overall Survival Predictions of Bladder Urothelial Carcinoma Patients.
Zhang M; Zhang X; Yu M; Zhang W; Zhang D; Zeng S; Wang X; Hu X
Front Oncol; 2021; 11():698856. PubMed ID: 34386423
[TBL] [Abstract][Full Text] [Related]
32. A Promising Esophageal Cancer Prognostic Signature of Ferroptosis-Related LncRNA to Predict Immune Scenery and Immunotherapy Response.
Liu X; Shi X; Guo W; Ke Y; Li Y; Pan S; Li X; Liu M; Liu M; Wang Y; Ruan Q; Ma H
Int J Gen Med; 2021; 14():5845-5862. PubMed ID: 34566425
[TBL] [Abstract][Full Text] [Related]
33. Identification of a Prognostic Signature Model with Tumor Microenvironment for predicting Disease-free Survival after Radical Prostatectomy.
Zhao H; Zhang X; Shi Z; Guo B; Zhang W; He K; Hu X; Shi S
J Cancer; 2021; 12(8):2371-2384. PubMed ID: 33758613
[No Abstract] [Full Text] [Related]
34. Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types.
Tang B; Yan R; Zhu J; Cheng S; Kong C; Chen W; Fang S; Wang Y; Yang Y; Qiu R; Lu C; Ji J
Int J Biol Sci; 2022; 18(1):180-198. PubMed ID: 34975326
[TBL] [Abstract][Full Text] [Related]
35. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.
Zhu W; Zeng H; Huang J; Wu J; Wang Y; Wang Z; Wang H; Luo Y; Lai W
J Transl Med; 2023 Nov; 21(1):782. PubMed ID: 37925432
[TBL] [Abstract][Full Text] [Related]
36. Construction on of a Ferroptosis-Related lncRNA-Based Model to Improve the Prognostic Evaluation of Gastric Cancer Patients Based on Bioinformatics.
Pan J; Zhang X; Fang X; Xin Z
Front Genet; 2021; 12():739470. PubMed ID: 34497636
[TBL] [Abstract][Full Text] [Related]
37. Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy.
Xu Z; Xie Y; Mao Y; Huang J; Mei X; Song J; Sun Y; Yao Z; Shi W
Front Genet; 2021; 12():758981. PubMed ID: 34804126
[TBL] [Abstract][Full Text] [Related]
38. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
39. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
[TBL] [Abstract][Full Text] [Related]
40. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
Zhao Y; Tao Z; Li L; Zheng J; Chen X
BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
